Health
A SARS-CoV-2 neutralizing antibody with extensive spike binding coverage – News-Medical.Net
In a recently published research paper in the journal Nature Communications, a team of scientists from China has described the antiviral efficacy of a novel anti-severe…
In a recently published research paper in the journal Nature Communications, a team of scientists from China has described the antiviral efficacy of a novel anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody isolated from recovered coronavirus disease 2019 (COVID-19) patients.
The structural and functional characterization of the antibody reveals that it covers most of the receptor-binding motif of the spike receptor-binding domain (RBD) and is highly potent in completely…
-
Business20 hours agoThe ultimate Australian stocks to buy and hold for 10+ years
-
Business24 hours agoThis artificial intelligence (AI) and “Magnificent Seven” stock will be the next company to surpass a $3 trillion market cap by the end of 2025
-
Noosa News24 hours agoYIMBYs vs NIMBYs as the battle for affordable housing moves into your backyard
-
Noosa News21 hours agoNew process turns wheat straw and oat husks into sustainable clothing